|University of Nevada School of Medicine|
|City: Reno||State: NV|
University of Nevada, Reno COI website
School of Medicine’s COI website
Summary: Overall, University of Nevada School of Medicine provided a good policy in need of some changes. Positively, purchasing and formulary committee members with financial conflicts of interest must recuse themselves from all committee decisions involving that pharmaceutical company. Also, no staff member covered under the policy is exempt from disclosing all pharmaceutical industry affiliations, which will be accessible on a public website, implemented in 2011. Unfortunately while all gifts are prohibited, all on-site meals are not prohibited. Moreover, long-term speaking relationships are not prevented in the policy. It is also unclear to what extent submitted policies apply to clinical educators as the policy does not extend to clinical partners.
Demographics: On average students spend 40% of their training at University Medical Center, 30% at Renown Regional Medical Center, and 30% at Veteran's Administration Hospitals in both Reno and Las Vegas. Submitted policies do not apply to any of these sites only to students and faculty of the university.
Updates: This institution submitted new policies for review for the 2012-3 AMSA PharmFree Scorecard, their grade remains a B.
This institution's evaluation was last updated: 4/9/2013
|Gifts & Meals||
No gifts, travel support, scholarships or training subsidies or training funds of any kind from industry will be permitted.
With regards to meals, on-site meals are only prohibited at "resident education meetings" and not other forums.
|Consulting relationships||Prior approval is requested via the "Consulting Activity Form." Consulting approvals must be obtained for each fiscal year even if the consulting work is ongoing or encompasses more than one fiscal year.|
|Industry-funded speaking relationships||The policy does not prevent long-term speaking relationships. However, employees must inform their supervisor of the speaking relationship.|
|Disclosure||Everyone covered under this policy will be required to make a full disclosure of all industry affiliations. Such disclosures will be displayed on a publicly accessible website|
Pharmaceutical samples will be restricted to patients with financial hardship. Each clinic will work towards centralized repository and distribution of samples and prohibition of on-site industry supported meals.
Although there is a stipluation that samples should only be used in cased of financial hardship, the policy does not define financial hardship in any way, leaving the category too broad. Nor does it indicate a specifc approval process for such an exception. Similarly a central distribution is encouraged but not clearly required.
|Purchasing & Formularies||All practice plan purchasing decisions will exclude individuals with potential industry conflicts.|
|Industry Sales Representatives||No industry representative will be permitted to market their products on medical school grounds or in associated clinics or offices unless invited to do so by the department head. Representatives will not be allowed in patient care areas.|
|On-campus Education||The policy restricts the industry from influencing the content or the speaker for CME activities.|
|Attendance at Industry-Sponsored Lectures & Meetings Off-Campus||The school prohibits travel support and trainee subsidies, but it is unclear if faculty and others would reasonably interpret this policy to mean they cannot accept compensation for attending a conference. Stronger language is suggested.|
|Industry Support for Scholarships & Funds for Trainees||No gifts, travel support, scholarships or training subsidies or training funds of any kind from from industry will be will be permitted.|
|Medical school curriculum||Curriculum Reading, Everyone's a Little Bit Biased; Curriculum - Med 605 Syllabus; Curriculum - Pharmacology class schedule|
|Do the policies specify an oversight mechanism?||Oversight is established via the Conflict of Interest Committee.|
|Are there explicit sanctions for noncompliance?||Sanctions for non-compliance are clearly noted.|
|Good progress toward model policy|
|No policy, or policy unlikely to have a substantial effect on behavior|
|Did not report|
|Policy not relevant to this institution (e.g., does not make purchasing decisions)|